Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany160232-08-6 tert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate 98%
tert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate
tert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate
tert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate

160232-08-6 tert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate 98%

Price Get Latest Price
Packge 1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-22

Product Details

  • Product Nametert-Butyl (2R,3S)-(1-benzyl-2-hydroxy-3-isobutylamino-propyl)-carbamate
  • CAS No.160232-08-6
  • EINECS No.605-203-3
  • MFC19H32N2O3
  • MW336.47
  • AppearanceSolidWhite
  • Melting point 145 °C
  • Boiling point 484.7±45.0 °C(Predicted)
  • density 1.039±0.06 g/cm3(Predicted)
  • storage temp. under inert gas (nitrogen or Argon) at 2–8 °C

Company Profile Introduction

We are a pharmaceutical company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. We have evolved our business and have, over the years, extended from manufacturing APIs and Intermediates to add CRAMS to our offerings, which has significant potential for the growth of our business.       

Ajit Kamath, aged 51 years, is the Executive Chairman and Managing Director of our Company and was first appointed as an Additional Director in our Company on January 1, 2001. He holds a Bachelors Degree in Commerce from the University of Mumbai and has around 19 years of experience in the pharmaceutical industry. Prior to joining our Company he has worked with CEAT Financial Services Limited and was one of the promoters of Arch Commerz Private Limited, which reverse-merged into our Company pursuant to the Scheme of Rehabilitation. He has been instrumental in the acquisitions made by our Company since our acquisition of the Gurgaon Unit in December 2004. He has been involved and instrumental in planning and formulating the overall business strategy and developing business relations for our Company.       

Arch Pharmalabs Ltd

1Y Maharashtra India
  • Since:2020-01-01
  • Address: Titanic Building, 3rd Floor, Tex Centre, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Maha
INQUIRY